Veeva launches Falcon Router to speed up safety and quality report routing for biopharma firms

Veeva Systems announced the Falcon Router, a new tool designed to quickly and accurately route safety adverse event reports, product quality complaints, and medical inquiries to the appropriate teams in biopharma companies. This automation reduces manual work and improves response times, especially as companies expand into new regions and products. Falcon Router will initially handle email and web inputs and integrate with Veeva's existing safety and quality management systems. It is set for early adopter release in January 2027, aiming to help biopharma experts focus more on patient care by streamlining triage processes.

Veeva Systems shares are trading at USD 259.50 on Pluang as of Sep 21, 2026 18:11 WIB, showing a slight decline of 0.27% for the day. The company holds a market cap of $42.13 billion and an enterprise value of $35.04 billion on the platform. This trading activity coincides with Veeva's announcement of the Falcon Router, a new tool aimed at improving efficiency in biopharma safety and quality management.